We’re sharing some interesting research results that we seen in the news recently. 

Are you looking for a clinical trial but not sure how to start or where to go? A new Clinical Trials Finder has been developed by Clinical Trials Ontario (CTO) to help you. You can search for a clinical trial in any province or territory in Canada, using only a few simple search terms.

We talked a lot on this blog last year about biosimilars; what they are and why it’s important to know about them. With the entry of biosimilars in the breast cancer treatment landscape due later this year, there are still questions and discussions about how it will affect current and future breast cancer patients. To help understand these questions and perspectives, we decided it was important to bring together those people who are impacted the most: patients and physicians.

In Part 1 we discussed the risk factors of lymphedema and tips for reducing this risk. Today we’re helping you identify early signs and what treatments are available for lymphedema.

Breast cancer-related lymphedema is abnormal swelling that can develop in the arm, hand, breast, or torso on the side treated for breast cancer where lymph nodes have been removed.  Lymphedema can develop suddenly or gradually. It can happen soon after surgery or can develop months or years later.

Canada’s new food guide is, in one word, refreshing! First off, it makes us hungry just looking at it. And secondly, it does away with the confusing portion sizes and focuses more on practical tips for incorporating healthier foods into our diets. 

We asked Tricia, a member of our patient advisory committee, to share her thoughts on our newest digital tool, the FinancialNavigator, designed to help connect patients with financial resources in their community. Here’s what she had to say.

When you are first told you have breast cancer, your thoughts can immediately turn to your mortality and how to best save your life. You worry about how your diagnosis will affect your family, spouse or kids. More and more, the realities of the disease begin to set in and the impact it can have on your finances becomes more apparent. 

It’s just the start of 2019 but we’re already thinking about fall and the federal election it brings with it. Last year, there was a lot of talk about the establishment of a national pharmacare plan. The federal government assembled a working group to study the best way a system like this would work in Canada.

February is here, which means Valentine’s Day is around the corner. Valentine’s is a day that you either love or hate. And throwing the C-word into the mix can make it hard even when it’s something you’re usually excited for.

World Cancer Day on February 4^th gives us a chance to reflect on 2018, the work we’ve accomplished and the work that still needs to be done. This year, WCD has a brand-new message: I Am And I Will.

Last month, we had the opportunity to attend the 2018 San Antonio Breast Cancer Symposium (SABCS). Here’s some of the key highlights to come out of the conference. 

Tell us a little bit about yourself, where you’re from, and your experience with breast cancer.

No person truly understands what it’s like to be diagnosed with breast cancer until it happens to them. It can be terrifying and overwhelming and can take physical and psychological tolls on a person’s body. 1 in every 8 Canadian women will hear the words “You have breast cancer” in her lifetime and 5,000 Canadians die from metastatic breast cancer each year. That means 26,000+ women every year have to live through surgery, chemo, radiation and side effects like fatigue, depression, chemo brain, and nausea, all while balancing their work and home life. Understanding the lived experience of a diagnosis like this is imperative to improving support for patients, survivors and their families.

Together we can accomplish great things! It’s always amazing to watch how individuals coming together as one united voice can truly make a difference in the lives of others.

Earlier this month, the annual meeting for the American Society of Clinical Oncology was held in Chicago. Here, key research developments in every area of cancer care are shared with oncology professionals from around the world. We’ve compiled the top breast cancer highlights to come out of this year’s ASCO 2018 conference:

I have been living with metastatic breast cancer for over eight years. While I am usually averse to using battle analogies for living with and dying from cancer, finding the best care has required a fight, considerable perseverance, and hard work. Fortunately, my ER+/PR+ tumours (pleura/liver/lymph) have responded well, but not great, to hormonal therapies.  I’m onto my seventh line of treatment. 

Now that you’ve learned more about biosimilars, it may also be of interest to learn what the physician perspective is. We connected with Dr. Sandeep Sehdev, a medical oncologist at the Ottawa Hospital, to get his perspective on biosimilars and what he thinks is important for patients to understand about them.

Biosimilar drugs will soon be entering the breast cancer treatment landscape and are already available for support medications. With these emerging treatment options, it’s important to know more about them so you can make informed decisions about your treatment plan.